ORTHO TRI-CYCLEN Drug Patent Profile
✉ Email this page to a colleague
When do Ortho Tri-cyclen patents expire, and what generic alternatives are available?
Ortho Tri-cyclen is a drug marketed by Janssen Pharms and is included in two NDAs.
The generic ingredient in ORTHO TRI-CYCLEN is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORTHO TRI-CYCLEN?
- What are the global sales for ORTHO TRI-CYCLEN?
- What is Average Wholesale Price for ORTHO TRI-CYCLEN?
Summary for ORTHO TRI-CYCLEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 20 |
Patent Applications: | 8 |
Drug Prices: | Drug price information for ORTHO TRI-CYCLEN |
DailyMed Link: | ORTHO TRI-CYCLEN at DailyMed |
Recent Clinical Trials for ORTHO TRI-CYCLEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gilead Sciences | Phase 1 |
Lexicon Pharmaceuticals | Phase 1 |
Aegerion Pharmaceuticals, Inc. | Phase 1 |
US Patents and Regulatory Information for ORTHO TRI-CYCLEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-21 | 019697-002 | Jul 3, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 019697-001 | Jul 3, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | ORTHO TRI-CYCLEN LO | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 021241-001 | Aug 22, 2002 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORTHO TRI-CYCLEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-21 | 019697-002 | Jul 3, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-21 | 019697-002 | Jul 3, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 019697-001 | Jul 3, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 019697-001 | Jul 3, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | ORTHO TRI-CYCLEN | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 019697-001 | Jul 3, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ORTHO TRI-CYCLEN
See the table below for patents covering ORTHO TRI-CYCLEN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 450108 | ⤷ Sign Up | |
Netherlands | 192206 | ⤷ Sign Up | |
Croatia | P940806 | ⤷ Sign Up | |
Philippines | 12003 | 3-OXIMES OF D-17ALPHA-ETHYNYL-19-NORTESTOSTERONE ESTERS AND METHOD | ⤷ Sign Up |
Yugoslavia | 173376 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ORTHO TRI-CYCLEN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1380301 | 2009C/007 | Belgium | ⤷ Sign Up | PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811 |
1453521 | 93156 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
1453521 | 39/2015 | Austria | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
1214076 | 49/2008 | Austria | ⤷ Sign Up | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON; REGISTRATION NO/DATE: 1-27586 20080612 |
1453521 | CA 2016 00016 | Denmark | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |